Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Intimate Rose vs Liberty

Intimate Rose
Graded #126

Higher grade

vs+8.299999999999997
Liberty
Graded #304

Lower grade

The verdict

Intimate Rose takes it — 69.3/100 to 61/100.

Intimate Rose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIntimate Rose +22
66
44
Dose & formulationIntimate Rose +19
96
77
Clinical oversightEven
76
76
Labs & monitoringLiberty +2
52
54
FulfillmentLiberty +17
64
81
Contract termsIntimate Rose +17
37
20
Intimate Rose · left barLiberty · right bar

The numbers

MetricIntimate RoseLiberty
WeighScore69.3/10061/100
GradeCC
Scorecard rank#126#304
Semaglutide$169/mo (all doses, compounded)$199/mo (compounded)
Tirzepatide$169/mo (all doses, compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Intimate Rose

Graded #126 · C

Strengths

  • Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
  • Medication and free delivery included, HSA and FSA eligible, no contract
  • Backed by an established women's-health brand using the OpenLoop provider network

Where it loses points

  • State availability not published
  • Oral compounded GLP-1 only; no injectable option shown
  • No specific compounding pharmacy named (network fulfillment via OpenLoop)
Liberty

Graded #304 · C

Strengths

  • Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
  • Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
  • Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
  • Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care

Where it loses points

  • Does not name its specific compounding pharmacy partner, only that it is a 503B facility
  • Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
  • Generic corporate branding (Liberty Health) with limited public detail on the operating entity
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard